Sign in
8-K

Current Report

Niagen Bioscience, Inc. Filed Acc 0001628280-22-006985

Regulation FD disclosure

  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading cdxc-20220323.htm…